Aura Biosciences, Inc. Common Stock (AURA) is a publicly traded Healthcare sector company. As of October 23, 2026, AURA trades at $6.62 with a market cap of $669.93M and a P/E ratio of -3.72. AURA moved +2.48% today. Year to date, AURA is +24.71%; over the trailing twelve months it is +12.15%. Its 52-week range spans $4.35 to $9.54. Analyst consensus is buy with an average price target of $20.50. Rallies surfaces AURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for AURA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $6.62 |
| Market Cap | $669.93M |
| P/E Ratio | -3.72 |
| EPS | $-1.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.54 |
| 52-Week Low | $4.35 |
| Volume | 33 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-106.19M |
| Gross Margin | 0.00% |
2 analysts cover AURA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.50.